Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L B To

Showing results (91-100 of 115) with videos related to

Pageof 12
Sort By:
Bone Marrow Transplantation|January 1, 1993
Effect of peripheral blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapyA Grigg, C G Begley, C A Juttner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 1995
Adjuvant treatment of high-risk breast cancer using multicycle high-dose chemotherapy and filgrastim-mobilized peripheral blood progenitor cellsR L Basser, L B To, C G Begley, et al.
Journal of Cellular Physiology|March 31, 2005
Osteoprotegerin (OPG) is localized to the Weibel-Palade bodies of human vascular endothelial cells and is physically associated with von Willebrand factorA C W Zannettino, C A Holding, P Diamond, et al.
Bone Marrow Transplantation|January 1, 1989
The optimization of collection of peripheral blood stem cells for autotransplantation in acute myeloid leukaemiaL B To, D N Haylock, D Thorp, et al.
Bone Marrow Transplantation|November 25, 1998
Granulocyte colony-stimulating factor (G-CSF) dose-dependent efficacy in peripheral blood stem cell mobilization in patients who had failed initial mobilization with chemotherapy and G-CSFA K Lie, C H Hui, T Rawling, et al.
Annals of Hematology|October 8, 2003
Prior and concurrent administration of recombinant human megakaryocyte growth and development factor in patients receiving consolidation chemotherapy for de novo acute myeloid leukemia--a randomized, placebo-controlled, double-blind safety and efficacy studyK Geissler, J A Liu Yin, A Ganser, et al.
Bone Marrow Transplantation|December 1, 1992
Non-haematological toxicity limiting the application of sequential high dose chemotherapy in patients with advanced breast cancerK B Pittman, L B To, J L Bayly, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 24, 2007
A prospective multicenter trial of peripheral blood stem cell sibling allografts for acute myeloid leukemia in first complete remission using fludarabine-cyclophosphamide reduced intensity conditioningA P Grigg, J Gibson, P G Bardy, et al.
Bone Marrow Transplantation|April 1, 1992
Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplantsL B To, M M Roberts, D N Haylock, et al.
Bone Marrow Transplantation|January 1, 1990
Approaches to blood stem cell mobilisation. Initial Australian clinical resultsC A Juttner, L B To, D N Haylock, et al.
Pageof 12

Showing results (91-100 of 115) with videos related to

Sort By:
Pageof 12
Bone Marrow Transplantation|January 1, 1993
Effect of peripheral blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapyA Grigg, C G Begley, C A Juttner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 1995
Adjuvant treatment of high-risk breast cancer using multicycle high-dose chemotherapy and filgrastim-mobilized peripheral blood progenitor cellsR L Basser, L B To, C G Begley, et al.
Journal of Cellular Physiology|March 31, 2005
Osteoprotegerin (OPG) is localized to the Weibel-Palade bodies of human vascular endothelial cells and is physically associated with von Willebrand factorA C W Zannettino, C A Holding, P Diamond, et al.
Bone Marrow Transplantation|January 1, 1989
The optimization of collection of peripheral blood stem cells for autotransplantation in acute myeloid leukaemiaL B To, D N Haylock, D Thorp, et al.
Bone Marrow Transplantation|November 25, 1998
Granulocyte colony-stimulating factor (G-CSF) dose-dependent efficacy in peripheral blood stem cell mobilization in patients who had failed initial mobilization with chemotherapy and G-CSFA K Lie, C H Hui, T Rawling, et al.
Annals of Hematology|October 8, 2003
Prior and concurrent administration of recombinant human megakaryocyte growth and development factor in patients receiving consolidation chemotherapy for de novo acute myeloid leukemia--a randomized, placebo-controlled, double-blind safety and efficacy studyK Geissler, J A Liu Yin, A Ganser, et al.
Bone Marrow Transplantation|December 1, 1992
Non-haematological toxicity limiting the application of sequential high dose chemotherapy in patients with advanced breast cancerK B Pittman, L B To, J L Bayly, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 24, 2007
A prospective multicenter trial of peripheral blood stem cell sibling allografts for acute myeloid leukemia in first complete remission using fludarabine-cyclophosphamide reduced intensity conditioningA P Grigg, J Gibson, P G Bardy, et al.
Bone Marrow Transplantation|April 1, 1992
Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplantsL B To, M M Roberts, D N Haylock, et al.
Bone Marrow Transplantation|January 1, 1990
Approaches to blood stem cell mobilisation. Initial Australian clinical resultsC A Juttner, L B To, D N Haylock, et al.
Pageof 12